Patents-Review.com
ClassID:

114691 ⎘

C12Y201/01043 - CPC Classification

Classification description:

Transferases transferring one-carbon groups (2.1); Methyltransferases (2.1.1) Histone-lysine N-methyltransferase (2.1.1.43)

Recent Application in this class:
#1
20250237652
2025-07-24

COMPOSITIONS AND METHODS RELATED TO THE METHYLATION OF HISTONE H1.0 PROTEIN

 #2
20250236870
2025-07-24

PERMANENT EPIGENETIC GENE SILENCING

 #3
20250179500
2025-06-05

PHARMACEUTICAL COMPOSITION COMPRISING SETMAR INHIBITOR FOR PREVENTING OR TREATING CANCER

 #4
20250011425
2025-01-09

COMPOSITIONS AND METHODS FOR IMPROVED T CELLS

 #5
20240255509
2024-08-01

COMPOSITIONS AND METHODS RELATED TO K180 DIMETHYLATED H1.0 PROTEIN

 #6
20240125783
2024-04-18

DETECTION OF MOLECULAR ASSOCIATIONS

 #7
20240093200
2024-03-21

COMPOSITIONS AND METHODS FOR IMPROVING IMMUNE SYSTEM FUNCTION

 #8
20230399640
2023-12-14

COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION

 #9
20230374549
2023-11-23

COMPOSITIONS AND METHODS FOR INHIBITING THE EXPRESSION OF MULTIPLE GENES

 #10
20230340471
2023-10-26

Permanent Epigenetic Gene Silencing

 #11
20230174978
2023-06-08

METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION

 #12
20230054672
2023-02-23

METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION

 #13
20230015276
2023-01-19

METHODS AND COMPOSITIONS TO INCREASE SOMATIC CELL NUCLEAR TRANSFER (SCNT) EFFICIENCY BY REMOVING HISTONE H3-LYSINE TRIMETHYLATION

 #14
20220378726
2022-12-01

Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide

 #15
20220290161
2022-09-15

RNA-REGULATED FUSION PROTEINS AND METHODS OF THEIR USE

 #16
20220119817
2022-04-21

Polycomb-associated Non-Coding RNAs

 #17
20210355465
2021-11-18

Engineered CRISPR-Cas9 Nucleases

 #18
20210302429
2021-09-30

Compositions and methods related to the methylation of histone H1.0 protein

 #19
20210155935
2021-05-27

Modulators of EZH2 expression

 #20
20200270573
2020-08-27

Compositions and methods for improved T cells

 #21
20200223895
2020-07-16

Therapeutic targeting of SET1B/compass pathway for treating cancers

 #22
20200181648
2020-06-11

METHODS AND COMPOSITIONS TO INCREASE HUMAN SOMATIC CELL NUCLEAR TRANSFER (SCNT) EFFICIENCY BY REMOVING HISTONE H3-LYSINE TRIMETHYLATION, AND DERIVATION OF HUMAN NT-ESC

 #23
20200149024
2020-05-14

Engineered CRISPR-Cas9 nucleases

 #24
20200088729
2020-03-19

Detection of molecular associations

 #25
20190309301
2019-10-10

Compositions and methods for improving immune system function

 #26
20190255106
2019-08-22

METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION

 #27
20190234948
2019-08-01

Compositions and methods related to the methylation of histone H1.0 protein

 #28
20190233805
2019-08-01

TARGETABLE PROTEINS FOR EPIGENETIC MODIFICATION AND METHODS FOR USE THEREOF

 #29
20190192533
2019-06-27

INHIBITION OF HISTONE METHYLTRANSFERASE FOR CARDIAC REPROGRAMMING

 #30
20190117751
2019-04-25

TUMOR ANTIGEN PEPTIDE

 #31
20190032049
2019-01-31

Permanent epigenetic gene silencing

 #32
20190024086
2019-01-24

Methods and compositions for modulating gene expression

 #33
20180363008
2018-12-20

Methods and compositions to increase somatic cell nuclear transfer (SCNT) efficiency by removing histone H3-lysine trimethylation

 #34
20180291400
2018-10-11

METHODS AND COMPOSITIONS TO INCREASE HUMAN SOMATIC CELL NUCLEAR TRANSFER (SCNT) EFFICIENCY BY REMOVING HISTONE H3-LYSINE TRIMETHYLATION, AND DERIVATION OF HUMAN NT-ESC

 #35
20180256749
2018-09-13

Compositions and methods for modulating FMR1 expression

 #36
20180216088
2018-08-02

Engineered CRISPR-Cas9 nucleases

 #37
20180179525
2018-06-28

Methods and compositions for modulating gene expression

 #38
20180177750
2018-06-28

Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide

 #39
20170327846
2017-11-16

Methods and compositions to increase somatic cell nuclear transfer (SCNT) efficiency by removing histone H3-lysine trimethylation

 #40
20170168067
2017-06-15

CHROMATIN-ACTIVITY-BASED CHEMOPROTEOMIC (CHAC) METHODS AND SYSTEMS FOR DISEASE MARKER DISCOVERY AND DEVELOPMENT

 #41
20170044550
2017-02-16

Polycomb-associated non-coding RNAs

 #42
20170022504
2017-01-26

Polycomb-associated non-coding RNAs

 #43
20160376598
2016-12-29

Polycomb-associated non-coding RNAS

 #44
20160375050
2016-12-29

METHODS AND COMPOSITIONS INVOLVING CHITOSAN NANOPARTICLES

 #45
20160355813
2016-12-08

Polycomb-associated non-coding RNAs

 #46
20160355806
2016-12-08

Polycomb-associated non-coding RNAs

 #47
20160168546
2016-06-16

Reconstituted Histone Methyltransferase Complex and Methods of Identifying Modulators Thereof

 #48
20160137989
2016-05-19

Method of suppressing gene transcription through histone lysine methylation

 #49
20160068834
2016-03-10

Stablized EZH2 peptides

 #50
20160053258
2016-02-25

Composition for controlling stem cells pluripotency, containing LIN28A methylation inhibitor, and method for screening for LIN28A methylation inhibitor

 #51
20150297611
2015-10-22

Inhibition of histone methyltransferase for cardiac reprogramming

 #52
20150293099
2015-10-15

Method of treatment of SETDB1 expressing cancer

 #53
20150258175
2015-09-17

Method of treating cancer

 #54
20150212088
2015-07-30

Compositions and methods for detecting and treating colorectal cancer

 #55
20150150156
2015-05-28

METHODS AND COMPOSITIONS FOR REDUCING GENE EXPRESSION IN PLANTS

 #56
20140024099
2014-01-23

Biomarkers for non-hodgkin lymphomas and uses thereof

 #57
20120020953
2012-01-26

Diagnosis and treatment of cancer

 #58
20110123511
2011-05-26

Method of suppressing gene transcription through histone lysine methylation

 #59
20110064664
2011-03-17

METHODS AND COMPOSITIONS INVOLVING CHITOSAN NANOPARTICLES

 #60
20090298105
2009-12-03

RECONSTITUTED HISTONE METHYLTRANSFERASE COMPLEX AND METHODS OF IDENTIFYI NG MODULATORS THEREOF

 #61
20090191181
2009-07-30

Methods of modulating SMYD3 for treatment of cancer

 #62
20050266473
2005-12-01

Reconstituted histone methyltransferase complex and methods of identifying modulators thereof